BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hu X, Zhang Z, Ma D, Huettner PC, Massad LS, Nguyen L, Borecki I, Rader JS. TP53, MDM2, NQO1, and susceptibility to cervical cancer. Cancer Epidemiol Biomarkers Prev. 2010;19:755-761. [PMID: 20200430 DOI: 10.1158/1055-9965.epi-09-0886] [Cited by in Crossref: 44] [Cited by in F6Publishing: 47] [Article Influence: 3.7] [Reference Citation Analysis]
Number Citing Articles
1 Albosale AH, Garbuzova OA, Kovalenko KA, Mashkina EV. Polymorphism of TP53 gene and the risk of high human papillomavirus load in cervical epithelial cells. Gene Reports 2022;26:101456. [DOI: 10.1016/j.genrep.2021.101456] [Reference Citation Analysis]
2 Mostaid MS, Mumu SB, Haque MA, Sharmin S, Jamiruddin MR, Sayedur Rahman GM, Reza HM. Elevated serum expression of p53 and association of TP53 codon 72 polymorphisms with risk of cervical cancer in Bangladeshi women. PLoS One 2021;16:e0261984. [PMID: 34962972 DOI: 10.1371/journal.pone.0261984] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Ramachandran D, Dörk T. Genomic Risk Factors for Cervical Cancer. Cancers (Basel) 2021;13:5137. [PMID: 34680286 DOI: 10.3390/cancers13205137] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
4 Li X, Li Z, Yang M, Luo Y, Hu L, Xiao Z, Huang A, Huang J. Two tSNPs in BRIP1 are associated with breast cancer during TDT analysis. Mol Genet Genomic Med 2021;9:e1578. [PMID: 33403820 DOI: 10.1002/mgg3.1578] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Lakshmanakumar M, Jbb AJ, Nesakumar N. An Introduction to Cancer Biomarkers. Biomarkers and Biosensors for Cervical Cancer Diagnosis 2021. [DOI: 10.1007/978-981-16-2586-2_1] [Reference Citation Analysis]
6 Nissar S, Sameer AS, Banday MZ. Genetic Polymorphisms of Essential Immune Pathogenic Response Genes and Risk of Cervical Cancer. Genetic Polymorphism and cancer susceptibility 2021. [DOI: 10.1007/978-981-33-6699-2_7] [Reference Citation Analysis]
7 Verma HK, Farran B, Bhaskar LV. Immune response, inflammation pathway gene polymorphisms, and the risk of cervical cancer. Overcoming Drug Resistance in Gynecologic Cancers 2021. [DOI: 10.1016/b978-0-12-824299-5.00011-3] [Reference Citation Analysis]
8 Yang S, Zhao J, Li L. NAD(P)H: quinone oxidoreductase 1 gene rs1800566 polymorphism increases the risk of cervical cancer in a Chinese Han sample. Medicine 2020;99:e19941. [DOI: 10.1097/md.0000000000019941] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Rader JS, Pan A, Corbin B, Iden M, Lu Y, Vellano CP, Akbani R, Mills GB, Simpson P. Identification and validation of a prognostic proteomic signature for cervical cancer. Gynecol Oncol 2019;155:324-30. [PMID: 31477280 DOI: 10.1016/j.ygyno.2019.08.021] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Knobloch TJ, Peng J, Hade EM, Cohn DE, Ruffin MT 4th, Schiano MA, Calhoun BC, McBee WC Jr, Lesnock JL, Gallion HH, Pollock J, Lu B, Oghumu S, Zhang Z, Sears MT, Ogbemudia BE, Perrault JT, Weghorst LC, Strawser E, DeGraffinreid CR, Paskett ED, Weghorst CM. Inherited alterations of TGF beta signaling components in Appalachian cervical cancers. Cancer Causes Control 2019;30:1087-100. [PMID: 31435875 DOI: 10.1007/s10552-019-01221-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
11 Tantengco OAG, Nakura Y, Yoshimura M, Llamas-Clark EF, Yanagihara I. Association of PIK3CA and MDM2 SNP309 with Cervical Squamous Cell Carcinoma in a Philippine Population. Asian Pac J Cancer Prev 2019;20:2103-7. [PMID: 31350972 DOI: 10.31557/APJCP.2019.20.7.2103] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
12 Rader JS, Tsaih SW, Fullin D, Murray MW, Iden M, Zimmermann MT, Flister MJ. Genetic variations in human papillomavirus and cervical cancer outcomes. Int J Cancer 2019;144:2206-14. [PMID: 30515767 DOI: 10.1002/ijc.32038] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 3.7] [Reference Citation Analysis]
13 da Rocha Boeira T, Coser J, Wolf JM, Cardinal BKM, Grivicich I, Simon D, Lunge VR. Polymorphism Located in the Upstream Region of the RPS19 Gene (rs2305809) Is Associated With Cervical Cancer: A Case-control Study. J Cancer Prev 2018;23:147-52. [PMID: 30370260 DOI: 10.15430/JCP.2018.23.3.147] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
14 Coelho A, Nogueira A, Soares S, Assis J, Pereira D, Bravo I, Catarino R, Medeiros R. TP53 Arg72Pro polymorphism is associated with increased overall survival but not response to therapy in Portuguese/Caucasian patients with advanced cervical cancer. Oncol Lett 2018;15:8165-71. [PMID: 29731921 DOI: 10.3892/ol.2018.8354] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
15 Duan X, Li J. Association between MDM2 SNP309, p53 Arg72Pro, and hepatocellular carcinoma risk: A MOOSE-compliant meta-analysis. Medicine (Baltimore) 2017;96:e7856. [PMID: 28885338 DOI: 10.1097/MD.0000000000007856] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
16 Alsbeih GA, Al-Harbi NM, Bin Judia SS, Khoja HA, Shoukri MM, Tulbah AM. Reduced rate of human papillomavirus infection and genetic overtransmission of TP53 72C polymorphic variant lower cervical cancer incidence. Cancer 2017;123:2459-66. [PMID: 28393355 DOI: 10.1002/cncr.30635] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
17 Jiao Y, Jiang Z, Wu Y, Chen X, Xiao X, Yu H. A Functional Polymorphism (rs937283) in the MDM2 Promoter Region is Associated with Poor Prognosis of Retinoblastoma in Chinese Han Population. Sci Rep 2016;6:31240. [PMID: 27506496 DOI: 10.1038/srep31240] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
18 Roszak A, Misztal M, Sowińska A, Jagodziński PP. Murine Double-Minute 2 Homolog Single Nucleotide Polymorphisms 285 and 309 in Cervical Carcinogenesis. Mol Diagn Ther 2015;19:235-44. [PMID: 26224627 DOI: 10.1007/s40291-015-0153-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
19 Duvlis S, Hiljadnikova Bajro M, Plaseska Karanfilska D. Association of p53Pro72Arg (rs1042522) and MDM2309 (rs2279744) polymorphisms with risk for cervical intraepthelial lesions and cervical cancer development in Macedonian women. Maced Pharm Bull 2016;62:49-58. [DOI: 10.33320/maced.pharm.bull.2016.62.02.006] [Reference Citation Analysis]
20 Yuan F, Sun R, Chen P, Liang Y, Ni S, Quan Y, Huang J, Zhang L, Gao L. Combined analysis of pri-miR-34b/c rs4938723 and TP53 Arg72Pro with cervical cancer risk. Tumour Biol 2016;37:6267-73. [PMID: 26619844 DOI: 10.1007/s13277-015-4467-y] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 2.6] [Reference Citation Analysis]
21 Tan SC, Ankathil R. Genetic susceptibility to cervical cancer: role of common polymorphisms in apoptosis-related genes. Tumour Biol. 2015;36:6633-6644. [PMID: 26242271 DOI: 10.1007/s13277-015-3868-2] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 3.3] [Reference Citation Analysis]
22 Osman NATAG, Abd El-Maqsoud NMR, El Gelany SAA. Correlation of NQO1 and Nrf2 in Female Genital Tract Cancer and Their Precancerous Lesions (Cervix, Endometrium and Ovary). World J Oncol 2015;6:364-74. [PMID: 28983331 DOI: 10.14740/wjon931w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
23 Yan ZH, Cui LH, Wang XH, Li C, He X. Comparative study of mutations in SNP loci of K-RAS, hMLH1 and hMSH2 genes in neoplastic intestinal polyps and colorectal cancer. World J Gastroenterol 2014; 20(48): 18338-18345 [PMID: 25561800 DOI: 10.3748/wjg.v20.i48.18338] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
24 Ma Y, Kong J, Yan G, Ren X, Jin D, Jin T, Lin L, Lin Z. NQO1 overexpression is associated with poor prognosis in squamous cell carcinoma of the uterine cervix. BMC Cancer. 2014;14:414. [PMID: 24912939 DOI: 10.1186/1471-2407-14-414] [Cited by in Crossref: 51] [Cited by in F6Publishing: 57] [Article Influence: 6.4] [Reference Citation Analysis]
25 Freriksen JJ, Salomon J, Roelofs HM, Te Morsche RH, van der Stappen JW, Dura P, Witteman BJ, Lacko M, Peters WH. Genetic polymorphism 609C>T in NAD(P)H:quinone oxidoreductase 1 enhances the risk of proximal colon cancer. J Hum Genet 2014;59:381-6. [PMID: 24830960 DOI: 10.1038/jhg.2014.38] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
26 Zhuo X, Ren J, Li D, Wu Y, Zhou Q. MDM2 SNP309 variation increases cervical cancer risk among Asians. Tumour Biol 2014;35:5331-7. [PMID: 24532430 DOI: 10.1007/s13277-014-1695-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
27 Ma D, Hovey RL, Zhang Z, Fye S, Huettner PC, Borecki IB, Rader JS. Genetic variations in EGFR and ERBB4 increase susceptibility to cervical cancer. Gynecol Oncol 2013;131:445-50. [PMID: 23927961 DOI: 10.1016/j.ygyno.2013.07.113] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
28 Alsbeih G, Al-Harbi N, El-Sebaie M, Al-Badawi I. HPV prevalence and genetic predisposition to cervical cancer in Saudi Arabia. Infect Agent Cancer 2013;8:15. [PMID: 23642098 DOI: 10.1186/1750-9378-8-15] [Cited by in Crossref: 37] [Cited by in F6Publishing: 42] [Article Influence: 4.1] [Reference Citation Analysis]
29 Gordon OK. Cancer of the Breast and Female Reproductive Tract. Emery and Rimoin's Principles and Practice of Medical Genetics 2013. [DOI: 10.1016/b978-0-12-383834-6.00093-8] [Reference Citation Analysis]
30 Mandal RK, Nissar K, Mittal RD. Genetic variants in metabolizing genes NQO1, NQO2, MTHFR and risk of prostate cancer: a study from North India. Mol Biol Rep 2012;39:11145-52. [PMID: 23054000 DOI: 10.1007/s11033-012-2023-z] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]